0001671284-23-000021.txt : 20230525 0001671284-23-000021.hdr.sgml : 20230525 20230525162457 ACCESSION NUMBER: 0001671284-23-000021 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20230519 ITEM INFORMATION: Material Modifications to Rights of Security Holders ITEM INFORMATION: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20230525 DATE AS OF CHANGE: 20230525 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Bright Health Group Inc. CENTRAL INDEX KEY: 0001671284 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] IRS NUMBER: 474991296 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40537 FILM NUMBER: 23961020 BUSINESS ADDRESS: STREET 1: 8000 NORMAN CENTER DRIVE STREET 2: SUITE 900 CITY: MINNEAPOLIS STATE: MN ZIP: 55437 BUSINESS PHONE: 612-238-1321 MAIL ADDRESS: STREET 1: 8000 NORMAN CENTER DRIVE STREET 2: SUITE 900 CITY: MINNEAPOLIS STATE: MN ZIP: 55437 FORMER COMPANY: FORMER CONFORMED NAME: Bright Health Inc. DATE OF NAME CHANGE: 20160404 8-K 1 bhg-20230519.htm 8-K bhg-20230519
0001671284December 31false8000 Norman Center Drive Suite 900MinneapolisMinnesota00016712842023-05-192023-05-1900016712842023-01-012023-12-31


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

Date of Report (date of earliest event reported) May 19, 2023

Bright Health Group, Inc.
(Exact name of registrant as specified in its charter)
Delaware
001-40537
47-4991296
(State or other jurisdiction of incorporation or organization)
(Commission File Number)
(I.R.S. Employer Identification No.)
8000 Norman Center Drive Suite 900, Minneapolis, Minnesota
55437
Address of Principal Executive Office(Zip Code)
(612) 238-1321
Registrant's telephone number, including area code

Not Applicable
(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, par value $0.0001 per shareBHGNew York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
o



Item 3.03 Material Modification to Rights of Security Holders.

On May 19, 2023 (the “Effective Date”), Bright Health Group, Inc. (the “Company”) filed a Certificate of Amendment to the
Ninth Amended and Restated Certificate of Incorporation of the Company with the Secretary of State of the State of Delaware
(the “Certificate of Amendment”) to effect a 1-for-80 reverse stock split (the “Reverse Split”) of the outstanding shares of the
Company’s common stock, par value $0.0001 per share (the “Common Stock”), effective as of 5:00 p.m., Eastern
Time on the Effective Date. No fractional shares will be issued in connection with the Reverse Split and stockholders will
receive cash in lieu of fractional shares.

The Common Stock began trading on a Reverse Split-adjusted basis on the New York Stock Exchange when the market opened
on May 22, 2023. The trading symbol for the Common Stock remains “BHG.” The Common Stock was assigned a new CUSIP
number (10920V 404) in connection with the Reverse Split.

The foregoing description of the Certificate of Amendment does not purport to be complete and is qualified in its entirety by
reference to the Certificate of Amendment, a copy of which is filed as Exhibit 3.1 to this Current Report on Form 8-K and is
incorporated herein by reference.

Item 5.03 Amendment to Articles of Incorporation or Bylaws; Change in Fiscal Year.

The disclosures included in Item 3.03 above are incorporated by reference in their entirety into this Item 5.03.
Item 8.01 Other Events.

In connection with the Reverse Split, the Company has adjusted the number of shares available for future grant under its
Amended and Restated 2021 Omnibus Incentive Plan, as well as the number of outstanding awards, the exercise price per share
of outstanding stock options and other terms of outstanding awards issued to reflect the effects of the Reverse Split. In addition,
the conversion rate for each of the Company’s Series A Convertible Perpetual Preferred Stock and Series B Convertible
Perpetual Preferred Stock was proportionately adjusted to give effect to the Reverse Split.

The Company currently has active registration statements (the “Registration Statements”) on Form S-8 (Nos. 333-257477 and 333-271987) on file with the Securities and Exchange Commission (the “SEC”). SEC regulations permit the Company to incorporate by reference future filings made with the SEC pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act prior to the termination of the offerings covered by Registration Statements filed on Form S-8. The information incorporated by reference is considered to be part of the prospectus and prospectus supplements included within each of those Registration Statements. Information in this report is therefore intended to be automatically incorporated by reference into each of the Registration Statements, thereby amending them. Pursuant to Rule 416(b) under the Securities Act of 1933, as amended, as a result and upon completion of the Reverse Split, the number of undistributed shares of Common Stock deemed to be covered by each of the Registration Statements will be proportionately reduced to a number of shares of Common Stock, as applicable, giving effect to the Reverse Split at the ratio of 1:80.

Item 9.01    Financial Statements and Exhibits.

(d) Exhibits.
Exhibit
No.
Description
3.1
104The cover page from the Current Report on Form 8-K formatted in Inline XBRL.



SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

BRIGHT HEALTH GROUP, INC.
Date:May 25, 2023By:/s/ Jeff Craig
Name:Jeff Craig
Title:General Counsel and Corporate Secretary


EX-3.1 2 ex31certificateofamendment.htm EX-3.1 Document
Exhibit 3.1
CERTIFICATE OF AMENDMENT
TO THE
NINTH AMENDED AND RESTATED
CERTIFICATE OF INCORPORATION OF
BRIGHT HEALTH GROUP, INC.
 
* * * * *

Bright Health Group, Inc., a corporation organized and existing under the laws of the State of Delaware (the “Corporation”), pursuant to the General Corporation Law of the State of Delaware (the “DGCL”), does hereby certify as follows:
 
1.That Article IV, Section I of the Ninth Amended and Restated Certificate of Incorporation of the Corporation is amended by adding the following paragraph at the end of Article IV, Section I as a new Section 4.I.G.:
 “G.    Upon the effectiveness of the Certificate of Amendment to the Ninth Amended and Restated Certificate of Incorporation adding this Section 4.I.G. (the “Effective Time”), each 15 to 80 shares of the Corporation’s Common Stock, par value $0.0001 per share, issued and outstanding immediately prior to the Effective Time shall automatically be combined into one (1) validly issued, fully paid and non-assessable share of Common Stock, par value $0.0001 per share, without any further action by the Corporation or the holder thereof, the exact ratio within the 15 to 80 range to be determined by the Board of Directors of the Corporation prior to the Effective Time and publicly announced by the Corporation, subject to the treatment of fractional share interests as described below (such combination, the “Reverse Stock Split”). No fractional shares shall be issued at the Effective Time and, in lieu thereof, the Corporation’s transfer agent shall aggregate all fractional shares and sell them as soon as practicable after the Effective Time at the then-prevailing prices on the open market, on behalf of those stockholders who would otherwise be entitled to receive a fractional share, and after the transfer agent’s completion of such sale, stockholders shall receive a cash payment (without interest or deduction) from the transfer agent in an amount equal to their respective pro rata shares of the total net proceeds of that sale and, where shares are held in certificated form, upon the surrender of the stockholder’s Old Certificates (as defined below). Each certificate that immediately prior to the Effective Time represented shares of Common Stock (“Old Certificates”) shall thereafter represent that number of whole shares of Common Stock into which the shares of Common Stock represented by the Old Certificate shall have been combined, subject to the treatment of fractional share interests as described above.”
 
2.On May 5, 2023, the Board of Directors of the Corporation determined that each eighty (80) shares of the Corporation's Common Stock, par value $0.0001 per share, issued and outstanding immediately prior to the Effective Time shall automatically be combined into one (1) validly issued, fully paid and non-assessable share of Common Stock, par value $0.001 per share. The Corporation publicly announced this ratio on May 9, 2023.


3.The foregoing amendment has been duly adopted in accordance with Section 242 of the DGCL.

4.This Certificate of Amendment shall become effective at 5:00 p.m. Eastern time on May 19, 2023.
IN WITNESS WHEREOF, this Certificate of Amendment to Ninth Amended and Restated Certificate of Incorporation has been executed by a duly authorized officer of the Corporation on this 19th day of May, 2023.




/s/ Jeff Craig
Name: Jeff Craig
Title: General Counsel and Corporate Secretary

2
EX-101.SCH 3 bhg-20230519.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Cover Page link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 bhg-20230519_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Entity Central Index Key Entity Central Index Key Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Trading Symbol Trading Symbol Entity File Number Entity File Number Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Soliciting Material Soliciting Material Entity Address, City or Town Entity Address, City or Town Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Local Phone Number Local Phone Number Entity Address, Postal Zip Code Entity Address, Postal Zip Code Written Communications Written Communications City Area Code City Area Code Cover [Abstract] Cover [Abstract] Title of 12(b) Security Title of 12(b) Security Document Type Document Type Amendment Flag Amendment Flag Current Fiscal Year End Date Current Fiscal Year End Date Security Exchange Name Security Exchange Name Entity Registrant Name Entity Registrant Name Entity Emerging Growth Company Entity Emerging Growth Company Entity Address, State or Province Entity Address, State or Province Document Period End Date Document Period End Date Pre-commencement Tender Offer Pre-commencement Tender Offer EX-101.PRE 5 bhg-20230519_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 6 R1.htm IDEA: XBRL DOCUMENT v3.23.1
Cover Page
12 Months Ended
May 19, 2023
Dec. 31, 2023
Cover [Abstract]    
Document Type 8-K  
Document Period End Date May 19, 2023  
Entity Registrant Name Bright Health Group, Inc.  
Entity Incorporation, State or Country Code DE  
Entity File Number 001-40537  
Entity Tax Identification Number 47-4991296  
Entity Address, Address Line One 8000 Norman Center Drive Suite 900  
Entity Address, City or Town Minneapolis  
Entity Address, State or Province MN  
Entity Address, Postal Zip Code 55437  
City Area Code 612  
Local Phone Number 238-1321  
Written Communications false  
Soliciting Material false  
Pre-commencement Tender Offer false  
Pre-commencement Issuer Tender Offer false  
Title of 12(b) Security Common Stock, par value $0.0001 per share  
Trading Symbol BHG  
Security Exchange Name NYSE  
Entity Emerging Growth Company false  
Entity Central Index Key 0001671284  
Amendment Flag false  
Current Fiscal Year End Date   --12-31
XML 7 bhg-20230519_htm.xml IDEA: XBRL DOCUMENT 0001671284 2023-05-19 2023-05-19 0001671284 2023-01-01 2023-12-31 0001671284 --12-31 false 8000 Norman Center Drive Suite 900 Minneapolis MN 8-K 2023-05-19 Bright Health Group, Inc. DE 001-40537 47-4991296 8000 Norman Center Drive Suite 900 Minneapolis MN 55437 612 238-1321 false false false false Common Stock, par value $0.0001 per share BHG NYSE false EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 11 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.1 html 2 23 1 false 0 0 false 0 false false R1.htm 0000001 - Document - Cover Page Sheet http://www.brighthealthgroup.com/role/CoverPage Cover Page Cover 1 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 3 fact(s) appearing in ix:hidden were eligible for transformation: dei:EntityAddressAddressLine1, dei:EntityAddressCityOrTown, dei:EntityAddressStateOrProvince - bhg-20230519.htm 4 bhg-20230519.htm bhg-20230519.xsd bhg-20230519_lab.xml bhg-20230519_pre.xml ex31certificateofamendment.htm http://xbrl.sec.gov/dei/2022 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "bhg-20230519.htm": { "axisCustom": 0, "axisStandard": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2022": 26 }, "contextCount": 2, "dts": { "inline": { "local": [ "bhg-20230519.htm" ] }, "labelLink": { "local": [ "bhg-20230519_lab.xml" ] }, "presentationLink": { "local": [ "bhg-20230519_pre.xml" ] }, "schema": { "local": [ "bhg-20230519.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 24, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2022": 6, "total": 6 }, "keyCustom": 0, "keyStandard": 23, "memberCustom": 0, "memberStandard": 0, "nsprefix": "bhg", "nsuri": "http://www.brighthealthgroup.com/20230519", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "bhg-20230519.htm", "contextRef": "i504f9ea790bb40f8af61551c6be9eb58_D20230519-20230519", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0000001 - Document - Cover Page", "menuCat": "Cover", "order": "1", "role": "http://www.brighthealthgroup.com/role/CoverPage", "shortName": "Cover Page", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "bhg-20230519.htm", "contextRef": "i504f9ea790bb40f8af61551c6be9eb58_D20230519-20230519", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.brighthealthgroup.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.brighthealthgroup.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.brighthealthgroup.com/role/CoverPage" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.brighthealthgroup.com/role/CoverPage" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.brighthealthgroup.com/role/CoverPage" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.brighthealthgroup.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.brighthealthgroup.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.brighthealthgroup.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.brighthealthgroup.com/role/CoverPage" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.brighthealthgroup.com/role/CoverPage" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.brighthealthgroup.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.brighthealthgroup.com/role/CoverPage" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.brighthealthgroup.com/role/CoverPage" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.brighthealthgroup.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.brighthealthgroup.com/role/CoverPage" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.brighthealthgroup.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.brighthealthgroup.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.brighthealthgroup.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.brighthealthgroup.com/role/CoverPage" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.brighthealthgroup.com/role/CoverPage" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.brighthealthgroup.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.brighthealthgroup.com/role/CoverPage" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.brighthealthgroup.com/role/CoverPage" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" } }, "version": "2.2" } ZIP 15 0001671284-23-000021-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001671284-23-000021-xbrl.zip M4$L#!!0 ( !R#N58:_E=_DAD )^F 0 8FAG+3(P,C,P-3$Y+FAT M;>T]:U/;NK;?SZ_0S;YW'SJ#@ORVTY8SE 2:[B:AD,(.7QC9EHD3Q\ZQ'2#\ M^KLD.^\$ A0(NW28@JWG6EIO+_HAB+-OM1?QC[E^T4 MR416Y@KCDJ(H)C$U#2N>YF+5MDQL$YMBIMNZJS++]G1E^[)$%$=S/-/#CFGR M:K*+35?V,-&(:MB6;:E4VW9+Q')LC6B44)VH5"8V,0W)565JJ+KM:(0/VTX! M.H P3$K^3?JYT$[3?FEGY_KZNGACQT$QBB]W_##P0\;!W4EC&B9>%/=H"NC8 M 2 ()C*6Y$+>R4WBSW1RK8@N9$*DG;]KWT^<-NM1[(=)2D.'%<9#+Q]9)I(R M-?RH.CQW5S4@R@XOMFDR[IV7^G?4GY^-RR:U1%&"! M&75W/_582A%OBME_!_[5Y\)^%*9 MK@Y[ /<3O;TN9"RFW1'=+6S^Z]__>M3 MZJYX(/-.Q9C!H6L6V5>";U=$G3 M)$>WF<5LS;PHCZ8RGE,!A;3'AV9^J1+"_(;[ $U,@VKHLIN_V+" ?!>Z=I73 MH5V.KK[+QU_LD5:S>MWJ[*GUVX-N MO?RM7;_](;=Z-:EV8)+O\OFP=>;HC<,?M_5F2ZTUV^U:N:O6#X][YX=5K=7< MNZ[?=I7S9DVKE??46N_GE7MXX-N'/_66_!/ZA7;ERG6K>:G6RUUXOKR%.L-Z M\P>I]\Y[Y_!\7N[F;4YA+"T\;_8[Y\TO?KU<(S688Z-\21KPW"C7AN?-JE0O M_Y"A9:]1KG<;I^;P>[.2UD[(#?R&>MUA;>_",%VB&ZZ!50EX7-5U"5/58O 7 M4R13 ^3;5F&7 &OKAB2;ZJ>=F66]R;4PUQ<:N).G$8!YUJ5'8]6B0L!=#FBP+VX<]&W(RNWV7XO>NO+EE_2Z(:B&D-:[)N8Q4T-J8,F)PZ M"O@$CJ9[!/1YS0]#1OM1X">OM= G*2CN1GP41U>^L,NGE#JWHDL)K]"'8M[! MNTJ_GQRT9>3@.KKGP'JX!D@"53)-3#V#8->CLN%YNJ%I=DX.2932!6+8F;7G M8^8QL,D/^"^EWC7CCDU33L!(^7RFGT(P\'D.AHXZ8(,_1D^_R9\\'T2@FQ):Z M=?O5OV:MX_G&NZ-7L[WW ;V1.WH"4H]3;MKN\DF!BX^Y#S9?-IZFNZ+JJ&3T M/!ID9P912_'V&%-]\_ FP<]Z>)-DK$@/Q=O.+/GM3+F].^ <9QZR0.=]49D+ MCKU)F]RK[ODA;C,>.2JIQ-QI?0H=IU"_QGC@(F ;^95ARA,:'#E-J!VQ4WXYB 4[41#0?L)*HS\^ MCIS]+(2!1:./>>]VE*913PQPQ>+4!T\M'T2,EQ5/H"B2#)(44):ZHY'SXJ(H MVDG=Q3+++%ID=3$I2N.R'=%W/*J0XQ,F6!#M "J.M<\%I3 '> Z*W$]1 HK1 M17\0\>]CG[JN'UZ6"))$+Y-A=@0NEN!^&;)7+=P:S4;E,/DH+HWFY0%=8H_V M_&!8^G?3[X%0KK-K=!R!5??O[82&">C1V/>RBHE_RTJ2"0LE'J\SO!C0CUC5 M'$^2H0(F?]:KS4H9G33WFI6339ZMS&GBI++_\[C:K%9.T%Z]C"I_[W_=JQ]6 MT'ZC5JN>G%0;]5<$0;T/!)4C_(PF;2"Q- JW4;FX7T0RT51KDS$OIGW0.*ZA M9S081X'W+(#YFO;?S \>J=G_*%:>N212P+JYJD8%7Q"+8,2K%KVAI3/0-,. ><.?S7 MO-V&5I+.E%:00)R-A!L.F >K2LRI5W&VTN+=FA0'9H$G/X[BY+5X'3C]N%)O MHN/*4>.XN1:4&S3[HT&<#&B8HC1")\SAX7\D*:AQC"1MR_V (@\UVXP7#6(_ M]6'@RHW3!B.;H3TGY<62I:A/A?K5E= \LM2ER.(F&0?YF/6C.$5;;O[,*!AE M+$D1N^)[XHBPP^1P>VD0R#H;;%->K\$VQ#B74\S/GL4Y9A=^@G?24SK M4/)[D1A7CMJ%89C,9+R\0E]/45N6&@A;@E,#E8#RF $03E/29PQUG%_DA\M,$ M@=X L1A_6$=;O'G_4)&+(%36\@\WI5OU(=[L*M=UY)K*_1LTI_*Y03>/\Y[O MN@$K+".#?*$63<*BH,XYFS![^?R,0>YCC(QM'"N=1Y/H\@'JW=2Z F^>]>OE+KW$(;7JU8:T<=!K-T\YY\Z!; MZ]06(]>]GR#$:W*C>="N]UJD=MA20: #'%68?TVKG]4#@&]8D\SK[\V]^<@U MLVW=4YB';<_FD6LJ8=.6=.SIGNQ1E=A,4OEF=$"O:;RX83D;&\O9;%GPASK= M2] *H8MS/) MJJ4QS\">H4C@SZLJ-@W=QK)A.9*M\A^-1\2AC&B*L9*>5U/R W5!)O#?=<%# M&:%);ZKY+H4C],$[5ZS-%=4%KM!5TV::@777L[ *GB&FBDJQ;BM4D8C.+"[D M57 A+4N2+7T-,?]N,=VM+@27; DC!D4QBM(VBU%G$/N)ZV<1*? M_&F#1U2+ M+VGHWXKG#VLKUW=D"V3O1[V>G_#<%P\ M*:)*KQ]$0R#:63&,ZE%Q&4KOWJC[)SG!FEZ4B?7+O543R$!_'A]8>P4?>)G= M\]L8+QN79ODDPZ71_ ;C.EH-C)-6_<=8:GC>_!;5F];91;G<; MY>JU,[ WC*55)K_E!;O:IVWH%VO9\W8-2HC<,?:BU8XIWN M6^3\[S9Q>J$X%[O$GZJO2[W+'*R8O[_4<)/(=9DI>\1\,U1 M.PK?\H;-DU;FYL+AE@O15>SIFHQ5QS.PY"4A:P/E]O%(H%W^;QVV# )2RBP)Y 72Y;"=),(% K MZHOQU/SE(_,)G]S_O5NU+R!*149B/4K17K\?@%X"F?_Z #\A7_5>*A, ;QV MN\;B/.4H%MX;/-+,8 R\U"6GNJBA/MW**#)*"-S/AA[7P;?B_-1ED_<9DX7 MI6V&:!_98#8>C,B\*8'#>CKO& M/M\Y2-!6PA@Z9"&+P3RKAM!VD.W7[!7E8C;=#Z7'94T^?G?@Y<6?_,PNUUGL MI["R?,]F$.9["\EBX,*.HL"FL$PI$,OOIV&'%Y9B.3*C+I9,3<4J,11LZCK! M5+=55[=-2[:-PNZ??UB&JGY\28VV)<1*! M10!K%%[60'F !@G>Q<6XGEQXLF6KMNE@S>;Q5D]CV%)-#7N*I;J6;A'% M<]^Y?NJ 8,RP,T5=]UH+D@HB=,O^L)X,R.J^2X%?+@6J23)@\;LL6"T+I LJ MN4QU=(I-C+,CK/E06 MO XC3WE!6=B$Q MHR=#0WV]6U<>TJVJ%(FR7D;A/?NL^9)DF< +][;DI?EQ^!67NKR-'<@FOXXW M._SNM)$3T"198T/V]T%/3,5FQ\FP9T?!5O+A5R$GSR?_)^.NGA\G%I3%1OH" M1.EUVX/N[5F]_;\\*#;.*QR6U*K-^OM\[/*8D90LZJ>G]5('5HV MFE52/_QQTVC6NZVS'VJK<]!I-+M233X(6JP71.Z\\(Z_D"B+3#^^,L@:C+!Q@M77#DQ1",;%-8!076,;6&,\5)<1PF:1( MFES8_?+U\+58X&5T]3^50T;:9.0Q9K?*S ;(C4=6DM@(F&5!+*XJ[F;X9._'W9Z0N)"-NH"]?#5T> MPF#('B)'9%^ J]P%:Y.)DZASJ1%^@F"*# "^Y ;^91Q=IVT>">GS= F:(, < M#"%NORC3OEH95)NZENB^NDE D1]LOOIEMO72HK^;/GED_ OI0P+R? M@?P>NYV+W:H7LB=93-%MS!Q/PZKL.IC*IH45@[B*;LBVZ:B_*G;[2RGH380W MJ]X=0HXG7XW=IY<,VS&C73#B04>5:'!-ATEA MYQDO)9_-C55'%C>0.%C;)X<->-YKR -*-KG[I.7R2_ VO@S3AR9T'Q#\%+W0X!-3([/ M.G31,1-'4]UY *JS-Z-D,BT'/A.>N;D8LY3&(J,WOVLE-R1'#Y.;RS8" S-K MN6+-QHL+:\<$M< "2Q@4"#8)UQ3 !GR[C#LM23_PTQD*.<[+3WC)N*L<+=$@ M%2$ORD@U!SQ1Y2\;'1.S%1F$&ZYT!P7DF&8<1)PS&QHQ'!=1:B1#4 M+_:*VZA">>P]W! D\,[XSH!0XS/2HHCJ$?)B*O0]B,U\":_]($ V R\N&60^ M&ICP86X5C)EEAC $\PFTMC.Y*CK9$ 3$S&$<9(K0A.,A.BZ$MB5@R.44J43^LQ:-OAKIA =EEQ%?4 M98D3^_T9I;W*,G$CF 7WG\"7$5?/@[H#(29\) :5N80"ZO_O -R3Z1N7^6U4 MH/6'X*=M" [&G\[*K:V5,&\C?DBP+\R5;-\7 ,Q-.![Q:OLVB&:E*&4=06'^ M<=;1[?S\:K/1&:D,/QN"@LE-=@!+&[ !BP5^]!@S#Z3E-=TMRRR\(.1W.#1: M[M#,V-U[?$G$RZ-VQ"VNF*$9$IFF#=X N,:/)ZP-?D+. &/TKL+)".QG#(\^ MDCHE8FP(>9I%L)4;(O!?X5_S>!N&4W4-';D]XQCRR-S8>.(%N>H%!LQ-97I% M_4"D&W*KPQND0+KH#W+/#3;A_WAMUD.P]7LMCQ 9?]V <^G$JOV @,S,T\\WBC?I:7R]&2 MW:H*KELO60[FR"4":0+BAL=L,[B%5S7R?>>L+D K/WHM(H?;&X()/DO@!3Y- MS@M]\ D/Q/3DH",7N.J?Z(Q;W60HF%3H2\II04D:(H6-8,U3 $ M?8A'0[),0U3FENM,,&ZT=\OKCOW3J6MYIR=S4MD?#5Q$\, A& 2CI'M@:3^= MD>VP=%,6Q*P!DT/>2[9(DVR_9YK\<_DOE9MGX V$+:?T@ M(KF?FA$0%SE^.!.V_Q3^,X<8S_,MD1Y[3O,)3Y$ MF/BN&"7SFOHT3D8F:C93=1\'EQ>DSQ[<6IZO(+0GS51N]C?,*AD$6:1LT(_"D69+ M3)&)TH41^=^SZC@EG#12,PW[SP@^Z&#A9IW31 IJ; M00;K^+:5;2XN.3;O$)B(9IPI9B3P5S+)!IGGKR.A5^^QKK\9]S1O6"++OG;, M,RLPC,=CIZ5DT.O1>/AQP_<'+?!7>*8/^;CX_\%XAWR*%3*%(\(GF^;;+ >3 M:YG5$UY^%)3O"<^>IGI+UZ9+9M$P'_>1K[O+3/G7?SK,,(J6]=R?#MO .U9S MDA2<4H\FA/F/OHUR.2K*DU#V(X[D+*9!;VP.]/+S2DI1^K6K_RC$+/NR /10 MN%MR>]ZS(2:;G,N M'06MB^T4N.V>5!+TA"2..[X22N=3FMZP;%W.41)17TR>KN:;5SDWVLY]&\1S MX9 71[W,M5^]N94YF6F^FR"L%O3WE^/OQ459O/)JX+>80"@I&Y)!N %?X\WN M)*@>UO>:/X\K)YMEUJ^(4DY%'[*LX?\._#AW4M8[X[ ]X_/GZ<;N /QZAPX2 ML:\Q";ED<8,\\R'*]L=MUJ:!QX,(O",A_O,*/&(RX $6T1T=I.TH!N#<)?G! M#_T*^"AY^.VX(Z2H6>M]&.E!=SGHS^*//--L5:.HF<:O=',>H+965M6?_,VI MUU!R7XZKAU^;Z&ME[WOS*SH\;OP\ MNFOK]$8Z7QG(HR,U?^V3'[ZZH^T\?" M7F/A>&)EZ0&6V5N 2>3<:5G.W3\,M"_#=1;K,=^;WCA0=Y(=](UY'MJ/J7_Y MF"^C/(\D> NXXP>KGT0HORQ>\:IH>">?)]P$]=L(FM%U]_L 1\("$=39'V^U MCT_9//4D_.8YYCMVY [A5SOM!;O_#U!+ P04 " <@[E6 3:)=G0" "3 M!P $ &)H9RTR,#(S,#4Q.2YX^O<#G7?"XIH.Q&:J)( ME;8?2A,EM\K %; IK;);OY]L!>T89.T0>JA>UDS\][,O/$,G)[MFAH]@)"4 MLY7EV:Z%@&4\IZQ<63?7ESBRSM:+Q>D'C.\^7VW0!<^Z!IA"YP*(@AQMJ:K0 M;0[R'A6"-^B6BWOZ0#!>&](Y;Q\%+2N%?-CF3@#/W(J($M0WTH!L209SLJ\7".GFT*;E0B'V:HRA M.UX==::>!*).*L SFY.Z? M\,C[%S4#2-O?@TFF(3,+OF#DP/5-^>_GEZ^!=<'K _3G(0QK@Q?6P9; MVU)6\+VA-^G"D['Z*RC&[7FQ$J^,B/E+B,@$K_\R3TXK> M"49#/U\D$J 04 M*ZM?*CP.[:^:I'9?R(AX$7]Z ]KM]!2H-P'N>:9\C7_NOR /D#\2,U%E7S^<=RGJ3 M-AC'E@X+YTPW;O_\;"N-8;_JZ\434$L#!!0 ( !R#N5;RYGUNSPH #)B M 4 8FAG+3(P,C,P-3$Y7VQA8BYX;6S575UOVS@6?>^OT&9?=H&RIDA* M(HNV@VZF712;:8LV16=WL3#XI4086PIDI4G^_5*RG5@Q98M4K'I>$L6^NCSW M6.=>?IEY]!+H7!8JRR]>GWP[?P_HR2]OGCU[]1< M?O_'E[/@UT)>SW5>!:>EYI56P4U670;?E5[\$:1E,0^^%^4?V0\.P)OFIM/B MZJ[,+BZK $&$'[];OL084TBC". T4H (1H& @@,=BU@1S40:X^<7+R&6D4QI M"B2EM1E2@"J4 AA!D@@F&.%1XW26Y7^\K'\(OM"!"2Y?-'^^/KFLJJN7D\G- MSV6_0UNK$/&V*1Y]]YTD=D,C=MP\OMO9U_E MI9YSD.6+BN>R;F"1O5PT+YX5DE<-YWMQ!9T6]5]@;0;JET"( Y?W"[4R9MG M0;"DHRQF^HM.@_KWMR\?.IMDD]IBDNN+^I/]K,NL4%\K7E9G7.B90=]XJ^ZN M].N313:_FNGU:Y>E3NUN9V79\EJC9#7*,*Y1_K6KL,1/]5@4%9^-\%@\ M-+,!>5:_<&:N5LW4CG8DTZ:=5>K>@*IO*YTKO'IF1T9,X5L89G5W8&B?!Q](?='_Z"O MA0'>A+[0\L5%\6-B[C44(%1?@/JBD56WQ\G6A_>V7./DI=S#\\IB(@O3U[FJ M0(ORNF_8,Z"JZ/FY+ZDSS9X$1:ET:?JOEA LS]\YO_V@C,\LS9:]L(_7(^M$Q3NWLPX1'M=P.>4"1 MW' V?#8G&MR_-Z>JS\E*;F68,P5I K M :!.&"!IR@'GA "L(,($A1'!K*](]S5V;*(U>('< !PL$0=+R$&#N;^,]U*] M7]9/2>"!93Z(.R?A]R7%*Q'L=3Y:8N@;YF:BZ'V/>^+X6LPRF56F8_ ;-UK, M^&RJ4&1B,KWGF&/3CXYY!+A@!,28I1C"!"(8]TT5V^Z/+3D\( S6$/OG @M[ M^]4_C),#Z]V%#B=Y=T?M)6B+N]$DW!W*IFAW6 VDYM;1#J.+'E M1]/(TUJ]&/*?TMKF8/B$UH;/GS.=M1U4YV26Q=17X!]R69171=G,BW^M3-XX M+:[SJKP[+92>1HJ2A#$&D!2)$;LD0%"$0"P4$RSB@F/D)O:=[1VI\%N8GP<- MZOKI7B$/:NBN>6 W[WUSPI.Q.4Y^&$2D1[KH1<^ U+';_\AII%>PVRFEWVWN MZ:7>LCC[?%GDZ[FG5"5*42X H@P! F,$!(HQX(HID@H,I0S[YI+'SH\M<33X M@@:@\Z3=%G'[D\$0.@ZL? %;*7FK>FL+QR;Z%_>16YZ/3FXUN."_:WC_BO.EX="2Z\N F^AL MT?JIKN5I/-G9 FCISFK@L4JLY;4IG'"G%'&*WUX2X;=WFNO]A_;FZ=4AA"3DU9))J9'U)"($C, M35G$A#"BJ,"BKS0W'1^;+.]/,ZC!]1=CBZO]0O1EX, B[!>\D_1LD7K)KN5H M-,G9X&_*S?J^N]3>&A^J]O-^QB^F!/$8I:$"9F1'ZV\1)X!%40AT'&H*6:A2 MU/O[12W/QR:V>W!!C:Z_VMIT[9>;-PD'UEO/^)T$9XW52W%M3Z-)SAK IN;L M!A[CONNRK+UD"\EG_]:\?)>K7WFEIPJ%*HR1!%S"V'1#D:EU89("J!3F0@H) M5=)["-C1R+%)<84S6 (-:J2!@1K46!U&AEV4]A@D/@%1AQXO^G#D-G;<0X+? M,+++Z7@CRCUAM0:7^VS]QYGO;N6E^3SU1_,93R6B!$D:@5#7W^N#"0%44P0B M":%FF(D(QYF8#QR;P-<9@#3*H4;H/-ULD]A]R^E)S8$D[LN(UZK2%/FCD MV7(X^NC3%HYM!&JU\]W.\$5?9/5\4UXUSUTD$R94J$&4,F4J=$2!J(^!0S)- M4AG"&$:.Y^RT&S@V\:[6Y1] .HK72N)^\0ZEYL#B=63%8Y."/?0!VQ,>.1QY M8X(]G.TM"1UVON)]-]?E199?_+,L;JK+TV)^Q?.[*<&A3AB1( VA-AJ.">"A M"$'">9P(Q54DB9N&K>T,(W)4K#Z'O9&* MWNU^1Y;]SN"VU;_;?."&Q&;W\:?RR_ .5-SU@K47V9\5J4LD8_:'6J[7'T M92IK0+;U*KOAX!-"-@^L2!@G.&4:A&ELU!Q!#*@*(8@H2\.$0R*D[]D@?Z93 M09[D.)!!!X'\28X .?C9'P,8SOMP.^G#Y8R/S4_BS%R]>;9^)5O^DX$W MS_X/4$L#!!0 ( !R#N5:60ZW5Z08 ! S 4 8FAG+3(P,C,P-3$Y M7W!R92YX;6S5FUMOVS@6Q]_[*;S>UV7,FW@)F@RRF781;&8:M!ET9E\,7@YM MH;)D4$J3?/LEE63:W&:$R$#4%SNF*9[#__F9/#Q2WOYTM:EF7R&V95,?S,D> MGL^@=HTOZ]7!_+?S]TC-?SI\\^;M/Q#Z_=\?3V<_-^YB W4W.XY@.O"SR[); MSSY[:+_,0FPVL\]-_%)^-0@=]A<=-]OK6*[6W8QBRAY^&_<98PJKHD L%!YQ MJQ6RV!H$P@K/0=L@V+]6^YBYP@45D%,J=Z,>*4\#P@7FTFJKN2GZ0:NR_K*? M7ZQI898F5[?]QX/YNNNV^XO%Y>7EWI6-U5X35PN*,5O<]9[?=K]ZU/^2];V) MUGK1?_MGU[9\JF,:EBQ^_^7TDUO#QJ"R;CM3NVR@+??;OO&T<:;K-?];OV;/ M]LB?T%TWE)L0H8B1O:O6SP_?S&8W6G81JZ[9@7(W84GNSF=IU@%B!']Z$Y5G)]?/K$OK+/0]=Q'Q,XAE MX]_5_N>T$"_!V4"=M$A2QQ%WU"#M@D7&B<([%EAJV4GH[YD=Q "=/@,OU_*5 M87A7=V5W_1%695:B[GXU&UA:097%BB*L"2#.A$1&*T!:*AQ$L)XH/8J%IZP. M0H%-%X712DZ"A).4O,5M$WOA/R7]X;BYJ+MX?=QX6'),F">&(Q%"F@XD;4Q0 M$@E)F!&D*'PA=@#&7SHQB!,^=4YVI_,DL'E?5O#KQ<9"7&I&A/ "(Q)<\EU( M@Q2U F'/;$K4N03*=L#(-XN#@"BF#L0+%9Q$],_-U8E/6I6AO#F5W$ZD,)H& MYRRRT@G$C1(H'[60I]YIR:5,8.\ A6?,#^)"3)V+76@["4B.O$\A:&_?TOD- MR-)256@ CPJ"->**%,@"A+3L>0P@F)96[0"0)TP/@D-.'8ZQFDX)C./TYX=X MWES62R"2 M$!!R=K#$A=/48(RP*_(\4FYD1'I1$!@S!2$I9=H=%P^L#X)#_R!PC%%V M2H2<-6UGJO^5VSYMEEP4P9"T]'&5I!$B+7U84U0H)T2:BI)R%^?6IVP/*V;A M'P2/E\OZRG#D1>\H@NG]QK* 0(&APG*+."4,&<4\HMI;'ES!M!A9A/W.VC M)ES.?+%TKQSR?">D.ELW]=WQ"2N2;'B.F T8<4D],H4V")0.1DHJB)*CPO[0 MXK#03[B*.4K"5P[_YUAV'=3'S69S4=\>D=HEDRPM6):@('(YOL %4IY#RH0# MY@RGK1/2 M4N9T8MGE$JSP%K 1CL*X(L1CF\,XF'"-R3@N.D[:] M@/C]7 BVA*83<8IK$(AK2Y&QU*2YX(+A7(L/=)>(//)@&"@3+ESN5.+7WE# M7:1-\9I0>UYV%2P%]9J#\HA1IE':_GA:!YE!02J/#2\TT>-*E@\M#L-APJ7* M41*^^"(I8 .1X(QT,"KV]\P- M"_R$RY$O%V\B/_IW5VYMZA7TM_*-L(%C%A!E5B%NJ$#*>(Q :P>%@,#DN. _ M9748 Q.N.HZ6HQHI*\$Z#<#%+NYK/C [C(D)ER#'B_G*-!RE?-?GG/=]959+ M#(XH#QH9;V0Z%>4I>(T1M*]]DV'BY@5>E^V MSE1_@(EWSX%JYCPC@:&D04ITI4S0DB!109D+@IK PKC'J9^S/(R%"15:;7/:2!+^ M?K^BU[G;.%<@$."78,=5CB$V6PE.87*I^W0U2",T:Z'1S8R,N5^_W3,2%M@X M3BX;DSL[)DCS]O3;TSTC'?_2NSP;__-C'V(S2^#CI[?O!V>P4V\T/K?/&HW> MN <7XP_OH>,U?1@KEFIAA$Q9TFCTASNP$QN3=1N-^7SNS=N>5-/&>-2@J3J- M1$K-O="$.R?'= <_.0M/_G+\2[T./1GD,YX:"!1GAH>0:Y%.X7/(]374ZT6O M,YDME)C&!EK-5AL^2W4M;IAK-\(D_*2AN $1OMD1 MK: =3=K1 >-1U&FVVX?!P7Z+3_C!P>N.WV9[__(19 .[NS':+!+^9F6\0(/S)"+E M)3H'J7\;BXDPT/;\XP9U+T6Z+QA34Y3-R*SKDV 5 0)4)E??78+6DR0XZX_& M@W>#L]-Q'R[?P>F'_K"'?^/CB3H97\+XHD_?AH/A^,(U]GMP.NS!J'\UQC$] M:EV;8S \NQQ]O!R=C@>70[RQJIF?0"=O1X/SBS%<]$_?H]3GH\M/'VLDE;=1 MDC\?>7,->>=!Y+^^\/>;1UL$\V$%_QV*WZ]&>D+^]O@HD88XHMO>S_Y\5GC8 M"F\=@5YPEI@8SI7,,_2?-/!JP* $7P4V8<'U%+NE8;W &-F?HQ^%.) JDXI1 MG@',*"S%L2&P- 1^*[2A/('@N (3:6$+D5-THU;]HU_P"_GA^?GS"UFL*!LFTA@YJU0.SP_<]Y[/MD<9"T,DZGK"(]-M'7@'>Z2' M<3U<94VRJ6!8#XJ(F[$Y3/0P1@X9!BNHI;W6\ M@7?N_41>7' L87:7ZY^?,A3+*B**2,@;I'*]S*]K%K!6LINX@OB_U7A+VZ#) M5G7[Q=3P_!F@7VH*:,'GI=.2\CD+8O#WR"Z'3= Q)EG]0(C0 /_@2..]V0QU M?F5D<%VCJ( ;EN0<_MKT$+(/&19;=I8:1I7."^/*W*!U4VL[,9OQ4*!UDP5D M2DA5^L2J>FB6) &6(UDBA O%C#A$,C9!.4) 3U(@DRQ)O!?$0@18@>W9@VB MG+IG3+CU4YG6F=;HH&R2< >0I/P*:>;"Q"@&3K? V14"5L"< R)GK#.*="5G M+).B^E1<1C47+[U2OI(\LG"=(6C@P*NSI'/W.V*R;?^G =\1NN-'?> 5=9(LPV MQ*P'0WE/^[H(%_29,NS,!N-C8*:0")ZONN5#P6[H%"\B1Y^2U8N(G$X5GQ([ MT]5](.1?FF,3SCHC7]"2B%NC4U+7P$8@BTRQ*UL'Z&#C7UK/%+]A(K'I5XF MB,G%BLQX"EA.77-3HWL3CL@B%P@2+:;)8B[V-,QCC#.9)Q@U)/!<8(<)Y6][ M#!B2W6,!TC*2S ML"&U6Q),&4?$(9@<PJ3K$6DG-:I"7 M98'.E>)V[UTL55'%4F^7R4J^U[!KN2-RC$?,@>[>IQ156VH:41S=2--9 M3%B1O4K\L+O5-+2NHVW@H,*5+8&XX%BJV5DGS6<39WH,OX1OTKS-X?-8H(&M MBSS.^-L?J*Q8MJ*?S]^ /]MH[8DE-K;%TIC>W:"9:(D_V3+W7^,M&KY M.W[/'7LTF9-Z,JCF-9(DU(C%2$=7^%\-Z2ZPR&,+GP7C8O[J" MSQ?]4?_R7,+(%S:^%%&$7_-N")MHF:#( M]X9L!%']C-4=*TQY?8(EWW7=EJE=ELS90N]\U;L;7UC3?AB7!4MY%%;O]#0G M89GFW?++42ATEK!%5Z36M>R@HU4.PD@[NB&OP/1GY&]L>F[:S[S7]_2=-V["0'6S4C,Y8^F:G MO;-&Y-U6=@L8E$#_'WBMM?1HVL)]4;FP'J_ZX]VS67V3: ML#G?7'PY ]02P$"% ,4 " <@[E6&OY7?Y(9 "?I@ $ M @ $ 8FAG+3(P,C,P-3$Y+FAT;5!+ 0(4 Q0 ( !R# MN58!-HEV= ( ),' 0 " < 9 !B:&'-D4$L! A0#% @ '(.Y5O+F?6[/"@ ,F( !0 ( ! M8AP &)H9RTR,#(S,#4Q.5]L86(N>&UL4$L! A0#% @ '(.Y5I9#K=7I M!@ $#, !0 ( !8R< &)H9RTR,#(S,#4Q.5]P&UL M4$L! A0#% @ '(.Y5G;;AM&&" DR@ !X ( !?BX M &5X,S%C97)T:69I8V%T96]F86UE;F1M96YT+FAT;5!+!08 !0 % $P! ( ! -P ! end